Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_assertion type Assertion NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_head.
- NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_provenance.
- NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_assertion evidence source_evidence_literature NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_provenance.
- NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_assertion SIO_000772 10897109 NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_provenance.
- NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_assertion wasDerivedFrom befree-2016 NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_provenance.
- NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_assertion wasGeneratedBy ECO_0000203 NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_provenance.